ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

NXTC NextCure Inc

1,48
-0,01 (-0,67%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
NextCure Inc NXTC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,67% 1,48 06:00:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,60 1,49 1,60 1,53 1,49
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05GLOBENextCure Provides Business Update and Reports First Quarter..
24.4.202422:05GLOBENextCure to Present Phase 1b Data of NC410 in Combination..
08.4.202413:00GLOBENextCure and LCB Present Preclinical Data on B7-H4 Antibody..
04.4.202413:05GLOBENextCure Appoints Dr. Rakesh Dixit to Scientific Advisory..
02.4.202413:00GLOBENextCure to Present at 23rd Annual Needham Virtual..
21.3.202413:55GLOBENextCure Provides Business Update and Reports Full Year 2023..
05.3.202414:05GLOBENextCure Publishes Preclinical Data Demonstrating Function..
01.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:05GLOBENextCure Presents Preclinical Data on a Novel Therapeutic..
21.12.202313:05GLOBENextCure Publishes Non-Clinical Data Demonstrating..
14.12.202313:15EDGAR2Form 8-K - Current report
14.12.202312:45GLOBENextCure Provides Year-End Clinical Pipeline Updates
20.11.202313:00GLOBENextCure to Present at the 35th Annual Piper Sandler..
15.11.202322:05GLOBENextCure Publishes Non-Clinical Data Defining the Mechanism..
02.11.202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:10EDGAR2Form 8-K - Current report
02.11.202321:05GLOBENextCure Provides Business Update and Reports Third Quarter..
17.10.202314:05GLOBEPreclinical Data Demonstrate Anti-Siglec-15 Treatment..
26.9.202322:05GLOBENextCure Presents Preclinical Data on NC181, a Novel..
12.9.202314:05GLOBEA Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in..
07.9.202322:05GLOBENextCure and Nordic Bioscience Publish Review Article on the..
05.9.202322:05GLOBEPreclinical Data Demonstrate Potential Application of..
31.8.202313:00GLOBENextCure to Present at the H.C. Wainwright 25th Annual..
04.8.202322:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
04.8.202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
03.8.202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:16EDGAR2Form 8-K - Current report
03.8.202322:05GLOBENextCure Provides Business Update and Reports Second Quarter..
19.7.202322:05EDGAR2Form 8-K - Current report
21.6.202322:05GLOBENextCure Presents Non-Clinical Data Defining the Mechanism..
09.5.202313:00GLOBENextCure to Present at the JMP Securities Life Sciences..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock